We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
-$225M
(-14%)
Cap. Flow
-$275M
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
53.86%
Holding
48
New
13
Increased
4
Reduced
14
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$94.2M |
| 2 |
ArcelorMittal
MT
|
+$58.7M |
| 3 |
SAFM
Sanderson Farms Inc
SAFM
|
+$54.5M |
| 4 |
Tyson Foods
TSN
|
+$49.8M |
| 5 |
Sysco
SYY
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
+$92.6M |
| 2 |
Royal Caribbean
RCL
|
+$60.7M |
| 3 |
Rio Tinto
RIO
|
+$57.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$52M |
| 5 |
Moelis & Co
MC
|
+$45.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.59% |
| 2 | Consumer Discretionary | 21.98% |
| 3 | Consumer Staples | 10.86% |
| 4 | Technology | 7.89% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
26
DELISTED
Amicus Therapeutics
FOLD
| $18.9M | 1.38% |
+1,511,000
| New | +$19.2M |
|
27
Alector
ALEC
$169M
| $12.3M | 0.9% |
645,782
-174,508
| -21% | -$3.54M |
|
28
Voyager Therapeutics
VYGR
$181M
| $8.08M | 0.59% |
296,773
-292,024
| -50% | -$6.68M |
|
29
Adaptive Biotechnologies
ADPT
$3.61B
| $5.84M | 0.43% |
+121,000
| New | +$5.36M |
|
30
PUT
Pinduoduo
PDD
$126B
| $3.61M | 0.26% |
+175,000
| New | +$3.79M |
|
|
HSACU
31
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
| $3.18M | 0.23% |
+300,000
| New | +$3.12M |
|
32
Arcturus Therapeutics
ARCT
$165M
| $2.06M | 0.15% |
217,866
+170,152
| +357% | +$1.25M |
|
33
Atara Biotherapeutics
ATRA
$72.6M
| – | – |
-11,087
| Closed | -$11M |
|
34
CALL
Las Vegas Sands
LVS
$32.2B
| – | – |
-1,580,000
| Closed | -$96.3M |
|
|
35
Las Vegas Sands
LVS
$32.2B
| – | – |
-566,900
| Closed | -$34.6M |
|
|
36
Moelis & Co
MC
$4.85B
| – | – |
-1,086,935
| Closed | -$45.2M |
|
37
Moderna
MRNA
$21.6B
| – | – |
-930,230
| Closed | -$18.9M |
|
38
Regenxbio
RGNX
$616M
| – | – |
-180,605
| Closed | -$10.3M |
|
|
39
Rio Tinto
RIO
$152B
| – | – |
-978,557
| Closed | -$57.6M |
|
40
PUT
VanEck Semiconductor ETF
SMH
$60.8B
| – | – |
-760,000
| Closed | -$40.4M |
|
|
41
Sarepta Therapeutics
SRPT
$1.64B
| – | – |
-436,000
| Closed | -$52M |
|
42
Target Hospitality
TH
$1.43B
| – | – |
-500,492
| Closed | -$4.75M |
|
43
Vale
VALE
$62.3B
| – | – |
-984,224
| Closed | -$12.9M |
|
|
BERY
44
DELISTED
Berry Global Group, Inc.
BERY
| – | – |
-1,872,331
| Closed | -$92.6M |
|
|
THWWW
45
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
| – | – |
-166,664
| Closed | -$257K |
|
|
I
46
DELISTED
INTELSAT S. A.
I
| – | – |
-774,876
| Closed | -$12.1M |
|
|
PVTL
47
DELISTED
Pivotal Software, Inc.
PVTL
| – | – |
-2,020,850
| Closed | -$42.1M |
|
|
STMP
48
DELISTED
Stamps.com, Inc.
STMP
| – | – |
-129,480
| Closed | -$10.5M |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Highline Capital Management held 48 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Highline Capital Management withdrew a net $275M in Q2 2019, closing 16 positions and reducing 14 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $92.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Highline Capital Management opened a new position in CATALENT, INC. worth $111M.
- Highline Capital Management's largest Q2 2019 buy was CATALENT, INC.: 2,056,709 shares worth $111M.
- Highline Capital Management added most to Commercial Metals in Q2 2019, an estimated $6.46M increase.
- Highline Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $60.7M.
- Highline Capital Management fully exited Berry Global Group, Inc. in Q2 2019, selling an estimated $92.6M.
- Highline Capital Management's ten largest holdings make up 54% of its $1.37B portfolio in Q2 2019.
- Highline Capital Management opened 13 new positions and closed 16 in Q2 2019.
- Highline Capital Management's portfolio value fell 14% quarter-over-quarter to $1.37B.
Based on Highline Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.